Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	12/4/2006 9:14:35 AM
	Read Replies (2) of 10280

Soleil Securities upgrades Sepracor (SEPR) to Buy, Says Far More Attractive Takeover Target 12-04-2006 08:17:37 AM Soleil Securities upgrades Sepracor (Nasdaq: SEPR) from Hold to Buy with a $67 price target citing improving fundamentals driven by an awakening in the previously sluggish insomnia market, a surge in Xopenex HFA (inhaler) prescriptions, and an apparent delay to Xopenex UDV reimbursement cuts. Analyst Matt Renna of Neponset Equity Research said, We believe now a far more attractive consolidation target and see the possible addition of SEPR's portfolio to the bag of a larger player as a means to improve sales force efficiency."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next